GSK wins US shingles vaccine approval, UK nod for gene therapy Ruby Khatun Khatun24 Oct 2017 10:30 AM ISTLONDON: GlaxoSmithKline (GSK) has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British...
Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination Ruby Khatun Khatun24 Oct 2017 10:00 AM ISTZURICH: Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and...
AstraZeneca among backers as Swiss cancer biotech raises 200 million dollars Ruby Khatun Khatun24 Oct 2017 9:30 AM ISTLONDON: An unlisted Swiss biotech company focused on developing “armed antibodies” to fight cancer has raised $200 million in a funding round backed...
ICMR proposes Suspension of Commercial Stem Cell Banking, Industry Reacts Ruby Khatun Khatun24 Oct 2017 9:09 AM ISTThe Indian Council of Medical Research (ICMR) had made recommendations in its National guidelines to stem cell research, 2017, to suspend commercial...
Now non-essential drugs fall under price control Ruby Khatun Khatun23 Oct 2017 5:45 PM ISTNew Delhi: The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming...
Healthcare IT companies raised 5.5 billion dollars in VC funding in Jan-Sep 2017 Ruby Khatun Khatun23 Oct 2017 1:46 PM ISTNew Delhi: Global healthcare IT/digital health companies have raised USD 5.5 billion in VC funding in January-September this year, more than in all of...
Merck cyber attack may cost insurers 275 million dollars: Verisks PCS Ruby Khatun Khatun23 Oct 2017 9:57 AM ISTNEW YORK: Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a...
Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 9:32 AM ISTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...
DBV Technologies peanut allergy drug fails key study Ruby Khatun Khatun23 Oct 2017 9:15 AM ISTDBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
Anpac Bio surpasses 50,000 case study milestone Liquid Biopsy Pioneer serving individual, medical, insurance and corporate customers Ruby Khatun Khatun23 Oct 2017 9:00 AM ISTSACRAMENTO, California: Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced...
No change in essential drugs ceiling price calculation: Government Ruby Khatun Khatun22 Oct 2017 11:48 AM ISTNew Delhi: The government said it is not considering any changes in the methodology for calculating ceiling prices of scheduled medicines although it...
Dr Reddys Lab recalls Famotidine tablets from US market Ruby Khatun Khatun22 Oct 2017 10:17 AM ISTNew Delhi: Dr. Reddy's Laboratories has initiated voluntarily recall of over half a million Famotidine tablets bottles from the US market as the drug...
